5
• the patient's goals and preferences
for treatment
• a review of psychiatric symptoms
and trauma history
• an assessment of tobacco use and
other substance use
• a psychiatric treatment history
• an assessment of physical health
• an assessment of psychosocial and
cultural factors
• a mental status examination,
including cognitive assessment
• an assessment of risk of suicide and
aggressive behaviors
• engaging support
• adherence
• addressing risks for suicide/
aggression
• addressing tobacco and SUDs
• addressing other comorbid
psychiatric symptoms, diagnoses
• addressing other comorbid health
conditions
• pregnancy/postpartum concerns
• treatment setting
• involuntary treatment issues
• needs of patients in correctional
settings
• coordinated specialty care program
(for first episode of psychosis)
• CBTp
• psychoeducation
• employment services
• assertive community treatment
• family interventions
• self-management skills and enhancing
person-oriented recovery
• cognitive remediation
• social skills
• supportive psychotherapy
Select based on:
• available formulations
• interactions and metabolism
• pharmacokinetic properties
• side-effect profile
Monitor for:
• side effects
• symptom response including non or
partial response
• adherence
Tardive dyskinesia
reversible inhibitor of the vesicular monoamine
transporter 2 (VMAT2)
Akathisia
• lowering the dosage of the antipsychotic medication
• switching to another antipsychotic medication
• adding a benzodiazepine medication, or
• adding a beta-adrenergic-blocking agent
Acute dystonia anticholinergic
Other side effects*
* See guideline for management and information on other side effects.
Parkinsonism
• lowering the dosage of the antipsychotic medication,
• switching to another antipsychotic medication, or
• treating with an anticholinergic medication
